Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); See 30% Upside in Next 12-Months
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); Positive Events Continue to Confirm Thesis
-
Auriga Maintains a 'Buy' on MedAssets (MDAS); Lowering Estimates and Price Target
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); A Beat and Decent Guide Should Offset Negative Sentiment
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); Tweaking Model While We Find Current Price Compelling
-
Auriga Cuts Price Target on MedAssets (MDAS), Maintains Buy Rating On After Hours Quote
-
Auriga Upgrades MedAssets (MDAS) to Buy; Valuation Now Compelling
